Epigenome-Extensive Affiliation Research Reveals Methylation Loci Related With Offspring Gestational Diabetes Mellitus Publicity and Maternal Methylome
Goal: Gestational diabetes mellitus (GDM) is related to an elevated danger of weight problems and insulin resistance in offspring later in life, which could be defined by epigenetic modifications in response to maternal hyperglycemic publicity.
Analysis design and strategies: We explored the affiliation between GDM publicity and maternal blood and new child wire blood methylation in 536 mother-offspring pairs from the possible FinnGeDi cohort utilizing Illumina MethylationEPIC 850Ok BeadChip arrays. We assessed two hypotheses. First, we examined for shared maternal and offspring epigenetic results ensuing from GDM publicity. Second, we examined whether or not GDM publicity and maternal methylation had an epigenetic impact on the offspring.
Outcomes: We didn’t discover any epigenetic marks (differentially methylated CpG probes) with shared and constant results between moms and offspring. After together with maternal methylation within the mannequin, we recognized a single vital (false discovery price 1.38 × 10-2) CpG on the cg22790973 probe (TFCP2) related to GDM. We recognized seven extra FDR-significant interactions of maternal methylation and GDM standing, with the strongest affiliation on the identical cg22790973 probe (TFCP2), in addition to cg03456133, cg24440941 (H3C6), cg20002843 (LOC127841), cg19107264, and cg11493553 situated throughout the UBE3C gene and cg17065901 in FAM13A, each susceptibility genes for sort 2 diabetes and BMI, and cg23355087 throughout the DLGAP2 gene, identified to be concerned in insulin resistance throughout being pregnant.
Conclusions: Our examine reveals the potential complexity of the epigenetic transmission between moms with GDM and their offspring, seemingly decided by not solely GDM publicity but additionally different elements indicated by maternal epigenetic standing, similar to maternal metabolic historical past.

RRAD Antibody |
|||
1-CSB-PA779820 | Cusabio |
|
|
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200 |
RRAD Antibody |
|||
R34275-100UG | NSJ Bioreagents | 100 ug | EUR 339.15 |
Description: Additional name(s) for this target protein: Ras-related associated with diabetes |
Polyclonal RRAD Antibody |
|||
APR05556G | Leading Biology | 0.1ml | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RRAD . This antibody is tested and proven to work in the following applications: |
RRAD Conjugated Antibody |
|||
C37229 | SAB | 100ul | EUR 476.4 |
GTP-binding protein RAD (RRAD) Antibody |
|||
20-abx241706 | Abbexa |
|
|
GTP-binding protein RAD (RRAD) Antibody |
|||
20-abx214509 | Abbexa |
|
|
GTP-binding protein RAD (RRAD) Antibody |
|||
20-abx324872 | Abbexa |
|
|
GTP-binding protein RAD (RRAD) Antibody |
|||
abx332370-100ul | Abbexa | 100 ul | EUR 510 |
GTP-Binding Protein RAD (RRAD) Antibody |
|||
abx432011-200ul | Abbexa | 200 ul | EUR 460.8 |
GTP-Binding Protein RAD (RRAD) Antibody |
|||
20-abx008742 | Abbexa |
|
|
Rrad/ Rat Rrad ELISA Kit |
|||
ELI-14921r | Lifescience Market | 96 Tests | EUR 1063.2 |
RRAD And GEM Like GTPase 2 (REM2) Antibody |
|||
abx237237-100ug | Abbexa | 100 ug | EUR 661.2 |
RRAD And GEM Like GTPase 2 (REM2) Antibody |
|||
abx122938-100ug | Abbexa | 100 ug | EUR 469.2 |
RRAD siRNA |
|||
20-abx932133 | Abbexa |
|
|
Polyclonal RRAD (aa36-48) Antibody (internal region) |
|||
APG00807G | Leading Biology | 0.1mg | EUR 580.8 |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human RRAD (aa36-48) (internal region). This antibody is tested and proven to work in the following applications: |
RRAD Peptide |
|||
43-008P | ProSci | 0.1 mg | EUR 405.6 |
Description: RRAD Peptide |
RRAD Blocking Peptide |
|||
20-abx063234 | Abbexa |
|
|
RRAD Blocking Peptide |
|||
33R-10070 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RRAD antibody, catalog no. 70R-5798 |
RRAD Blocking Peptide |
|||
33R-4793 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RRAD antibody, catalog no. 70R-5797 |
RRAD ELISA KIT|Human |
|||
EF005507 | Lifescience Market | 96 Tests | EUR 826.8 |
Human RRAD shRNA Plasmid |
|||
20-abx954199 | Abbexa |
|
|
RRAD Recombinant Protein (Rat) |
|||
RP226925 | ABM | 100 ug | Ask for price |
RRAD Recombinant Protein (Mouse) |
|||
RP169340 | ABM | 100 ug | Ask for price |
RRAD Recombinant Protein (Human) |
|||
RP095493 | ABM | 100 ug | Ask for price |
Rrad ORF Vector (Rat) (pORF) |
|||
ORF075643 | ABM | 1.0 ug DNA | EUR 607.2 |
RRAD ORF Vector (Human) (pORF) |
|||
ORF031832 | ABM | 1.0 ug DNA | EUR 486 |
Rrad ORF Vector (Mouse) (pORF) |
|||
ORF056448 | ABM | 1.0 ug DNA | EUR 607.2 |
Rrad sgRNA CRISPR Lentivector set (Rat) |
|||
K7052701 | ABM | 3 x 1.0 ug | EUR 406.8 |
Rrad 3'UTR GFP Stable Cell Line |
|||
TU168183 | ABM | 1.0 ml | Ask for price |
RRAD 3'UTR GFP Stable Cell Line |
|||
TU072380 | ABM | 1.0 ml | EUR 1672.8 |
Rrad 3'UTR GFP Stable Cell Line |
|||
TU269725 | ABM | 1.0 ml | Ask for price |
Rrad sgRNA CRISPR Lentivector set (Mouse) |
|||
K3480701 | ABM | 3 x 1.0 ug | EUR 406.8 |
RRAD sgRNA CRISPR Lentivector set (Human) |
|||
K2069901 | ABM | 3 x 1.0 ug | EUR 406.8 |
RRAD Protein Vector (Rat) (pPM-C-HA) |
|||
PV302572 | ABM | 500 ng | EUR 723.6 |
RRAD Protein Vector (Rat) (pPB-C-His) |
|||
PV302570 | ABM | 500 ng | EUR 723.6 |
RRAD Protein Vector (Rat) (pPB-N-His) |
|||
PV302571 | ABM | 500 ng | EUR 723.6 |
RRAD Protein Vector (Rat) (pPM-C-His) |
|||
PV302573 | ABM | 500 ng | EUR 723.6 |
RRAD Protein Vector (Human) (pPM-C-HA) |
|||
PV127328 | ABM | 500 ng | EUR 662.4 |
RRAD Protein Vector (Mouse) (pPM-C-HA) |
|||
PV225792 | ABM | 500 ng | EUR 723.6 |
RRAD Protein Vector (Human) (pPB-C-His) |
|||
PV127326 | ABM | 500 ng | EUR 662.4 |
RRAD Protein Vector (Human) (pPB-N-His) |
|||
PV127327 | ABM | 500 ng | EUR 662.4 |
RRAD Protein Vector (Human) (pPM-C-His) |
|||
PV127329 | ABM | 500 ng | EUR 662.4 |
RRAD Protein Vector (Mouse) (pPB-C-His) |
|||
PV225790 | ABM | 500 ng | EUR 723.6 |
RRAD Protein Vector (Mouse) (pPB-N-His) |
|||
PV225791 | ABM | 500 ng | EUR 723.6 |
RRAD Protein Vector (Mouse) (pPM-C-His) |
|||
PV225793 | ABM | 500 ng | EUR 723.6 |
Rrad 3'UTR Luciferase Stable Cell Line |
|||
TU118183 | ABM | 1.0 ml | Ask for price |
RRAD 3'UTR Luciferase Stable Cell Line |
|||
TU022380 | ABM | 1.0 ml | EUR 1672.8 |
Rrad 3'UTR Luciferase Stable Cell Line |
|||
TU219725 | ABM | 1.0 ml | Ask for price |
Rrad sgRNA CRISPR Lentivector (Rat) (Target 1) |
|||
K7052702 | ABM | 1.0 ug DNA | EUR 184.8 |
Rrad sgRNA CRISPR Lentivector (Rat) (Target 2) |
|||
K7052703 | ABM | 1.0 ug DNA | EUR 184.8 |
Rrad sgRNA CRISPR Lentivector (Rat) (Target 3) |
|||
K7052704 | ABM | 1.0 ug DNA | EUR 184.8 |
Rrad sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
K3480702 | ABM | 1.0 ug DNA | EUR 184.8 |
Rrad sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
K3480703 | ABM | 1.0 ug DNA | EUR 184.8 |
Rrad sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
K3480704 | ABM | 1.0 ug DNA | EUR 184.8 |
RRAD sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
K2069902 | ABM | 1.0 ug DNA | EUR 184.8 |
RRAD sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
K2069903 | ABM | 1.0 ug DNA | EUR 184.8 |
RRAD sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
K2069904 | ABM | 1.0 ug DNA | EUR 184.8 |
Rat GTP-binding protein RAD (RRAD) ELISA Kit |
|||
abx391893-96tests | Abbexa | 96 tests | EUR 1093.2 |
Human GTP- binding protein RAD, RRAD ELISA KIT |
|||
ELI-35549h | Lifescience Market | 96 Tests | EUR 988.8 |
Mouse GTP- binding protein RAD, Rrad ELISA KIT |
|||
ELI-14089m | Lifescience Market | 96 Tests | EUR 1038 |
Mouse GTP-binding protein RAD (RRAD) ELISA Kit |
|||
abx390415-96tests | Abbexa | 96 tests | EUR 1093.2 |
Human GTP-binding protein RAD (RRAD) ELISA Kit |
|||
abx385354-96tests | Abbexa | 96 tests | EUR 1093.2 |
RRAD Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV) |
|||
LV658369 | ABM | 1.0 ug DNA | EUR 616.8 |
RRAD Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
LV658373 | ABM | 1.0 ug DNA | EUR 616.8 |
RRAD Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
LV658374 | ABM | 1.0 ug DNA | EUR 616.8 |
Human RRAD And GEM Like GTPase 2 (REM2) ELISA Kit |
|||
abx382769-96tests | Abbexa | 96 tests | EUR 1093.2 |
Anti-RRAD (aa36-48) antibody |
|||
STJ72757 | St John's Laboratory | 100 µg | EUR 430.8 |
Rrad ELISA Kit| Rat GTP-binding protein RAD ELISA Kit |
|||
EF019253 | Lifescience Market | 96 Tests | EUR 826.8 |
Rrad ELISA Kit| Mouse GTP-binding protein RAD ELISA Kit |
|||
EF016057 | Lifescience Market | 96 Tests | EUR 826.8 |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
|||
K7052705 | ABM | 3 x 1.0 ug | EUR 451.2 |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|||
K3480705 | ABM | 3 x 1.0 ug | EUR 451.2 |
RRAD sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
K2069905 | ABM | 3 x 1.0 ug | EUR 451.2 |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1) |
|||
K7052706 | ABM | 1.0 ug DNA | EUR 200.4 |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2) |
|||
K7052707 | ABM | 1.0 ug DNA | EUR 200.4 |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3) |
|||
K7052708 | ABM | 1.0 ug DNA | EUR 200.4 |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
|||
K3480706 | ABM | 1.0 ug DNA | EUR 200.4 |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
|||
K3480707 | ABM | 1.0 ug DNA | EUR 200.4 |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
|||
K3480708 | ABM | 1.0 ug DNA | EUR 200.4 |
RRAD sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
K2069906 | ABM | 1.0 ug DNA | EUR 200.4 |
RRAD sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
K2069907 | ABM | 1.0 ug DNA | EUR 200.4 |
RRAD sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
K2069908 | ABM | 1.0 ug DNA | EUR 200.4 |
RRAD Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA) |
|||
LV658370 | ABM | 1.0 ug DNA | EUR 616.8 |
RRAD Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
|||
LV658371 | ABM | 1.0 ug DNA | EUR 686.4 |
RRAD Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
|||
LV658372 | ABM | 1.0 ug DNA | EUR 686.4 |
RRAGA / RRAGB Antibody |
|||
abx332724-100ul | Abbexa | 100 ul | EUR 510 |
RRAGA / RRAGB Antibody |
|||
20-abx328592 | Abbexa |
|
|
RRAGA/RRAGB Antibody |
|||
1-CSB-PA003930 | Cusabio |
|
|
Description: A polyclonal antibody against RRAGA/RRAGB. Recognizes RRAGA/RRAGB from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/20000 |
RRAGA/RRAGB Antibody |
|||
CSB-PA590465- | Cusabio | each | EUR 402 |
Description: A polyclonal antibody against RRAGA/RRAGB. Recognizes RRAGA/RRAGB from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000 |
RRAGA/RRAGB Antibody |
|||
CSB-PA590465-100ul | Cusabio | 100ul | EUR 379.2 |
Description: A polyclonal antibody against RRAGA/RRAGB. Recognizes RRAGA/RRAGB from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000 |
RRAS Antibody |
|||
37881-100ul | SAB | 100ul | EUR 302.4 |
RRAS antibody |
|||
70R-20022 | Fitzgerald | 50 ul | EUR 522 |
Description: Rabbit polyclonal RRAS antibody |
RRAS Antibody |
|||
1-CSB-PA020513GA01HU | Cusabio |
|
|
Description: A polyclonal antibody against RRAS. Recognizes RRAS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC |
RRAS Antibody |
|||
1-CSB-PA444135 | Cusabio |
|
|
Description: A polyclonal antibody against RRAS. Recognizes RRAS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100 |
RRAS Antibody |
|||
1-CSB-PA663638 | Cusabio |
|
|
Description: A polyclonal antibody against RRAS. Recognizes RRAS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100 |
RRAGC antibody |
|||
10R-1679 | Fitzgerald | 100 ug | EUR 614.4 |
Description: Mouse monoclonal RRAGC antibody |
RRAGA Antibody |
|||
40326-100ul | SAB | 100ul | EUR 302.4 |
RRAGC Antibody |
|||
40327-100ul | SAB | 100ul | EUR 302.4 |
RRAS2 Antibody |
|||
40328-100ul | SAB | 100ul | EUR 302.4 |
RRAS2 Antibody |
|||
7249-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: RRAS2 Antibody: Activating mutations and overexpression of classical Ras subfamily members (K-RAS, N-RAS and H-RAS) have been widely investigated as key events in the development of human cancers. The RRAS subfamily of Ras-related proteins includes RRAS1, RRAS2 (TC21) and RRAS3 (M-Ras) show overall amino acid identity with the classical Ras subfamily (H-Ras, K-Ras and N-Ras) of 55–60%. RRAS2 is a small GTPbinding protein of the Ras superfamily of GTPases. It might transduce growth inhibitory signals across the cell membrane, exerting its effect through an effector shared with the Ras proteins. RRAS2 has high oncogenic potential and overexpression/mutations have been reported in several tumor tissues and cell lines. |
RRAS2 Antibody |
|||
7249-01mg | ProSci | 0.1 mg | EUR 523.7 |
Description: RRAS2 Antibody: Activating mutations and overexpression of classical Ras subfamily members (K-RAS, N-RAS and H-RAS) have been widely investigated as key events in the development of human cancers. The RRAS subfamily of Ras-related proteins includes RRAS1, RRAS2 (TC21) and RRAS3 (M-Ras) show overall amino acid identity with the classical Ras subfamily (H-Ras, K-Ras and N-Ras) of 55–60%. RRAS2 is a small GTPbinding protein of the Ras superfamily of GTPases. It might transduce growth inhibitory signals across the cell membrane, exerting its effect through an effector shared with the Ras proteins. RRAS2 has high oncogenic potential and overexpression/mutations have been reported in several tumor tissues and cell lines. |
RRAGA antibody |
|||
70R-15303 | Fitzgerald | 100 ug | EUR 392.4 |
Description: Rabbit polyclonal RRAGA antibody |
RRAGB antibody |
|||
70R-20021 | Fitzgerald | 50 ul | EUR 522 |
Description: Rabbit polyclonal RRAGB antibody |
RRAS2 antibody |
|||
70R-20023 | Fitzgerald | 50 ul | EUR 522 |
Description: Rabbit polyclonal RRAS2 antibody |
RRAGD antibody |
|||
70R-3629 | Fitzgerald | 50 ug | EUR 560.4 |
Description: Rabbit polyclonal RRAGD antibody raised against the middle region of RRAGD |
RRAGC antibody |
|||
70R-3630 | Fitzgerald | 50 ug | EUR 560.4 |
Description: Rabbit polyclonal RRAGC antibody raised against the N terminal of RRAGC |
RRAS2 antibody |
|||
70R-50868 | Fitzgerald | 100 ul | EUR 292.8 |
Description: Purified Polyclonal RRAS2 antibody |
RRAGD Antibody |
|||
46175-100ul | SAB | 100ul | EUR 302.4 |
RRAGD Antibody |
|||
46175-50ul | SAB | 50ul | EUR 224.4 |
RRAGC Antibody |
|||
ABD13245 | Lifescience Market | 100 ug | EUR 525.6 |
RRAGB Antibody |
|||
ABD4393 | Lifescience Market | 100 ug | EUR 525.6 |
RRAGC Antibody |
|||
ABD4394 | Lifescience Market | 100 ug | EUR 525.6 |
RRAGA Antibody |
|||
ABD7957 | Lifescience Market | 100 ug | EUR 525.6 |
RRAGD Antibody |
|||
ABD9812 | Lifescience Market | 100 ug | EUR 525.6 |
RRAS2 Antibody |
|||
ABD9840 | Lifescience Market | 100 ug | EUR 525.6 |
RRAGB Antibody |
|||
1-CSB-PA006486 | Cusabio |
|
|
Description: A polyclonal antibody against RRAGB. Recognizes RRAGB from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/40000 |
RRAGD Antibody |
|||
DF9812 | Affbiotech | 200ul | EUR 420 |
RRAS2 Antibody |
|||
DF9840 | Affbiotech | 200ul | EUR 420 |
RRAGA Antibody |
|||
DF7957 | Affbiotech | 200ul | EUR 420 |
RRAGB Antibody |
|||
DF4393 | Affbiotech | 200ul | EUR 420 |
RRAGC Antibody |
|||
DF4394 | Affbiotech | 200ul | EUR 420 |
RRAGA Antibody |
|||
1-CSB-PA03465A0Rb | Cusabio |
|
|
Description: A polyclonal antibody against RRAGA. Recognizes RRAGA from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:50-1:200, IF:1:50-1:500 |
RRAGC Antibody |
|||
1-CSB-PA038367 | Cusabio |
|
|
Description: A polyclonal antibody against RRAGC. Recognizes RRAGC from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;ELISA:1:2000-1:5000, WB:1:500-1:2000 |
RRAGC Antibody |
|||
1-CSB-PA003932 | Cusabio |
|
|
Description: A polyclonal antibody against RRAGC. Recognizes RRAGC from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/10000 |
RRAGA Antibody |
|||
1-CSB-PA071515 | Cusabio |
|
|
Description: A polyclonal antibody against RRAGA. Recognizes RRAGA from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100 |
RRAGC Antibody |
|||
1-CSB-PA867190ESR1HU | Cusabio |
|
|
Description: A polyclonal antibody against RRAGC. Recognizes RRAGC from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200 |
RRAGC Antibody |
|||
1-CSB-PA931417 | Cusabio |
|
|
Description: A polyclonal antibody against RRAGC. Recognizes RRAGC from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:25-1:100 |
RRAGA Antibody |
|||
1-CSB-PA022239 | Cusabio |
|
|
Description: A polyclonal antibody against RRAGA. Recognizes RRAGA from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:25-1:100 |
RRAGB Antibody |
|||
1-CSB-PA020510GA01HU | Cusabio |
|
|
Description: A polyclonal antibody against RRAGB. Recognizes RRAGB from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB |
RRAS2 Antibody |
|||
1-CSB-PA020514ESR2HU | Cusabio |
|
|
Description: A polyclonal antibody against RRAS2. Recognizes RRAS2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200 |
RRAS2 Antibody |
|||
1-CSB-PA020514GA01HU | Cusabio |
|
|
Description: A polyclonal antibody against RRAS2. Recognizes RRAS2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC |
RRAS2 Antibody |
|||
1-CSB-PA350769 | Cusabio |
|
|
Description: A polyclonal antibody against RRAS2. Recognizes RRAS2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;ELISA:1:2000-1:5000, WB:1:500-1:2000 |
RRAGD Antibody |
|||
F54410-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 140.25 |
Description: Ras-related GTP-binding protein D is a monomeric guanine nucleotide-binding protein, or G protein. By binding GTP or GDP, small G proteins act as molecular switches in numerous cell processes and signaling pathways. |
RRAGD Antibody |
|||
F54410-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 322.15 |
Description: Ras-related GTP-binding protein D is a monomeric guanine nucleotide-binding protein, or G protein. By binding GTP or GDP, small G proteins act as molecular switches in numerous cell processes and signaling pathways. |
R-Ras Antibody |
|||
DF10319 | Affbiotech | 200ul | EUR 420 |
anti- RRAS antibody |
|||
FNab07489 | FN Test | 100µg | EUR 658.5 |
Description: Antibody raised against RRAS |
R-Ras2 Antibody |
|||
abx140418-01mg | Abbexa | 0.1 mg | EUR 510 |
RRAGA/B Antibody |
|||
34965-100ul | SAB | 100ul | EUR 302.4 |
RRAGA/B Antibody |
|||
34965-50ul | SAB | 50ul | EUR 224.4 |
RRAGA/B Antibody |
|||
ABD4392 | Lifescience Market | 100 ug | EUR 525.6 |
RRAGA / B Antibody |
|||
20-abx014789 | Abbexa |
|
|
RRAGA/B Antibody |
|||
DF4392 | Affbiotech | 200ul | EUR 420 |
anti- RRAGB antibody |
|||
FNab07488 | FN Test | 100µg | EUR 658.5 |
Description: Antibody raised against RRAGB |
anti- RRAS2 antibody |
|||
FNab07490 | FN Test | 100µg | EUR 658.5 |
Description: Antibody raised against RRAS2 |
RRAGA antibody (HRP) |
|||
60R-1741 | Fitzgerald | 100 ug | EUR 392.4 |
Description: Rabbit polyclonal RRAGA antibody (HRP) |
RRAGA antibody (FITC) |
|||
60R-1742 | Fitzgerald | 100 ug | EUR 392.4 |
Description: Rabbit polyclonal RRAGA antibody (FITC) |
R-Ras2 Antibody (PE) |
|||
abx140419-01mg | Abbexa | 0.1 mg | EUR 777.6 |
Human RRAS2 Antibody |
|||
32052-05111 | AssayPro | 150 ug | EUR 313.2 |
R-Ras (pY66) Antibody |
|||
abx218392-100ug | Abbexa | 100 ug | EUR 526.8 |
RRAGA antibody (biotin) |
|||
60R-1743 | Fitzgerald | 100 ug | EUR 392.4 |
Description: Rabbit polyclonal RRAGA antibody (biotin) |
IL- 13Ralpha1 Antibody |
|||
ABF9095 | Lifescience Market | 100 ug | EUR 525.6 |
Ras-Related Protein R-Ras (RRAS) Antibody |
|||
abx237489-100ug | Abbexa | 100 ug | EUR 610.8 |
Ras-related protein R-Ras (RRAS) Antibody |
|||
20-abx241995 | Abbexa |
|
|
Ras-related protein R-Ras (RRAS) Antibody |
|||
20-abx214133 | Abbexa |
|
|
Ras-Related Protein R-Ras (RRAS) Antibody |
|||
abx026316-400ul | Abbexa | 400 ul | EUR 627.6 |
Ras-Related Protein R-Ras (RRAS) Antibody |
|||
abx026316-80l | Abbexa | 80 µl | EUR 343.2 |
Ras-Related Protein R-Ras (RRAS) Antibody |
|||
20-abx123552 | Abbexa |
|
|
RRAS Conjugated Antibody |
|||
C37881 | SAB | 100ul | EUR 476.4 |
RRAS Polyclonal Antibody |
|||
ABP60258-003ml | Abbkine | 0.03ml | EUR 189.6 |
Description: A polyclonal antibody for detection of RRAS from Human, Mouse, Rat. This RRAS antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human RRAS protein at amino acid sequence of 1-80 |
RRAS Polyclonal Antibody |
|||
ABP60258-01ml | Abbkine | 0.1ml | EUR 346.8 |
Description: A polyclonal antibody for detection of RRAS from Human, Mouse, Rat. This RRAS antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human RRAS protein at amino acid sequence of 1-80 |
RRAS Polyclonal Antibody |
|||
ABP60258-02ml | Abbkine | 0.2ml | EUR 496.8 |
Description: A polyclonal antibody for detection of RRAS from Human, Mouse, Rat. This RRAS antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human RRAS protein at amino acid sequence of 1-80 |
RRAS Polyclonal Antibody |
|||
ES9011-100ul | ELK Biotech | 100ul | EUR 334.8 |
Description: A Rabbit Polyclonal antibody against RRAS from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
RRAS Polyclonal Antibody |
|||
ES9011-50ul | ELK Biotech | 50ul | EUR 248.4 |
Description: A Rabbit Polyclonal antibody against RRAS from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
Polyclonal RRAS2 Antibody |
|||
APR06809G | Leading Biology | 0.1 mg | EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RRAS2 . This antibody is tested and proven to work in the following applications: |
Polyclonal RRAS2 Antibody |
|||
APR05586G | Leading Biology | 0.1ml | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RRAS2 . This antibody is tested and proven to work in the following applications: |
RRAGA Conjugated Antibody |
|||
C40326 | SAB | 100ul | EUR 476.4 |
RRAGC Conjugated Antibody |
|||
C40327 | SAB | 100ul | EUR 476.4 |
RRAS2 Conjugated Antibody |
|||
C40328 | SAB | 100ul | EUR 476.4 |
RRAGD Conjugated Antibody |
|||
C46175 | SAB | 100ul | EUR 476.4 |
RRAGA Polyclonal Antibody |
|||
A70742 | EpiGentek |
|
|
RRAGA Polyclonal Antibody |
|||
A51649 | EpiGentek |
|
|
R51A1 Polyclonal Antibody |
|||
ABP60055-003ml | Abbkine | 0.03ml | EUR 189.6 |
Description: A polyclonal antibody for detection of R51A1 from Human, Mouse. This R51A1 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human R51A1 protein at amino acid sequence of 90-170 |
R51A1 Polyclonal Antibody |
|||
ABP60055-01ml | Abbkine | 0.1ml | EUR 346.8 |
Description: A polyclonal antibody for detection of R51A1 from Human, Mouse. This R51A1 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human R51A1 protein at amino acid sequence of 90-170 |
R51A1 Polyclonal Antibody |
|||
ABP60055-02ml | Abbkine | 0.2ml | EUR 496.8 |
Description: A polyclonal antibody for detection of R51A1 from Human, Mouse. This R51A1 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human R51A1 protein at amino acid sequence of 90-170 |
RRAGD Polyclonal Antibody |
|||
ABP60257-003ml | Abbkine | 0.03ml | EUR 189.6 |
Description: A polyclonal antibody for detection of RRAGD from Human, Mouse. This RRAGD antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human RRAGD protein at amino acid sequence of 140-220 |
RRAGD Polyclonal Antibody |
|||
ABP60257-01ml | Abbkine | 0.1ml | EUR 346.8 |
Description: A polyclonal antibody for detection of RRAGD from Human, Mouse. This RRAGD antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human RRAGD protein at amino acid sequence of 140-220 |
RRAGD Polyclonal Antibody |
|||
ABP60257-02ml | Abbkine | 0.2ml | EUR 496.8 |
Description: A polyclonal antibody for detection of RRAGD from Human, Mouse. This RRAGD antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human RRAGD protein at amino acid sequence of 140-220 |
RRAS2 Polyclonal Antibody |
|||
ABP60259-003ml | Abbkine | 0.03ml | EUR 189.6 |
Description: A polyclonal antibody for detection of RRAS2 from Human, Mouse. This RRAS2 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human RRAS2 protein at amino acid sequence of 90-170 |
RRAS2 Polyclonal Antibody |
|||
ABP60259-01ml | Abbkine | 0.1ml | EUR 346.8 |
Description: A polyclonal antibody for detection of RRAS2 from Human, Mouse. This RRAS2 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human RRAS2 protein at amino acid sequence of 90-170 |
RRAS2 Polyclonal Antibody |
|||
ABP60259-02ml | Abbkine | 0.2ml | EUR 496.8 |
Description: A polyclonal antibody for detection of RRAS2 from Human, Mouse. This RRAS2 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human RRAS2 protein at amino acid sequence of 90-170 |
R51A1 Polyclonal Antibody |
|||
ES10084-100ul | ELK Biotech | 100ul | EUR 334.8 |
Description: A Rabbit Polyclonal antibody against R51A1 from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA |
R51A1 Polyclonal Antibody |
|||
ES10084-50ul | ELK Biotech | 50ul | EUR 248.4 |
Description: A Rabbit Polyclonal antibody against R51A1 from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA |
RRAGD Polyclonal Antibody |
|||
ES10110-100ul | ELK Biotech | 100ul | EUR 334.8 |
Description: A Rabbit Polyclonal antibody against RRAGD from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA |
RRAGD Polyclonal Antibody |
|||
ES10110-50ul | ELK Biotech | 50ul | EUR 248.4 |
Description: A Rabbit Polyclonal antibody against RRAGD from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA |
RRAS2 Polyclonal Antibody |
|||
ES10138-100ul | ELK Biotech | 100ul | EUR 334.8 |
Description: A Rabbit Polyclonal antibody against RRAS2 from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA |
RRAS2 Polyclonal Antibody |
|||
ES10138-50ul | ELK Biotech | 50ul | EUR 248.4 |
Description: A Rabbit Polyclonal antibody against RRAS2 from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA |
RRAGA/B Conjugated Antibody |
|||
C34965 | SAB | 100ul | EUR 476.4 |
RRAGA Antibody, HRP conjugated |
|||
1-CSB-PA03465B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against RRAGA. Recognizes RRAGA from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
RRAGA Antibody, FITC conjugated |
|||
1-CSB-PA03465C0Rb | Cusabio |
|
|
Description: A polyclonal antibody against RRAGA. Recognizes RRAGA from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
Polyclonal RRAS Antibody (Center) |
|||
APR03572G | Leading Biology | 0.1ml | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RRAS (Center). This antibody is tested and proven to work in the following applications: |
R-Ras (Phospho-Tyr66) Antibody |
|||
12780-100ul | SAB | 100ul | EUR 302.4 |
R-Ras (Phospho-Tyr66) Antibody |
|||
12780-50ul | SAB | 50ul | EUR 224.4 |
Polyclonal RRAGD Antibody (Center) |
|||
AMM07666G | Leading Biology | 0.1ml | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RRAGD (Center). This antibody is tested and proven to work in the following applications: |
RRAGA Antibody, Biotin conjugated |
|||
1-CSB-PA03465D0Rb | Cusabio |
|
|
Description: A polyclonal antibody against RRAGA. Recognizes RRAGA from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
Related RAS Viral (R-Ras) Oncogene Homolog 2 (RRAS2) Antibody |
|||
abx237490-100ug | Abbexa | 100 ug | EUR 610.8 |
Related RAS Viral (R-Ras) Oncogene Homolog 2 (RRAS2) Antibody |
|||
20-abx213490 | Abbexa |
|
|
Related RAS Viral (R-Ras) Oncogene Homolog 2 (RRAS2) Antibody |
|||
abx146436-100ug | Abbexa | 100 ug | EUR 469.2 |
Related RAS Viral (R-Ras) Oncogene Homolog 2 (RRAS2) Antibody |
|||
20-abx321839 | Abbexa |
|
|
Related Ras Viral (R-Ras) Oncogene Homolog 2 (RRAS2) Antibody |
|||
20-abx115122 | Abbexa |
|
|
Metformin use is related to a decreased danger of acute appendicitis in Taiwanese sufferers with sort 2 diabetes mellitus
This retrospective cohort examine used the nationwide database of Taiwan’s Nationwide Well being Insurance coverage to analyze whether or not metformin would cut back the chance of acute appendicitis in sufferers with sort 2 diabetes mellitus. We first recognized 423,949 sufferers newly recognized of diabetes from 1999 to 2005. After excluding sufferers having sort 1 diabetes mellitus, lacking knowledge, earlier historical past of acute appendicitis, aged < 15 years, aged > 80 years and adopted up for < 6 months, 338,172 ever customers and 21,861 by no means customers of metformin had been adopted up from January 1, 2006 till December 31, 2011.
Incidence of acute appendicitis was estimated for by no means customers, ever customers and subgroups (divided by median, tertiles and quartiles, respectively) of dose-response indicators together with cumulative period (months), cumulative dose (mg) and common day by day dose (mg/day) of metformin remedy. We used Cox regression included with the inverse chance of remedy weighting utilizing propensity rating to estimate the general hazard ratio for ever versus by no means customers, and the hazard ratios for subgroups of dose-response indicators versus by no means customers.
Outcomes confirmed that new-onset acute appendicitis was recognized in 1558 ever customers and 179 by no means customers throughout follow-up. The incidence was 98.15 per 100,000 person-years in ever customers and was 189.48 per 100,000 person-years in by no means customers. The general hazard ratio (95% confidence interval) of 0.514 (0.441-0.600) instructed a decrease danger of acute appendicitis related to metformin use. A dose-response sample was constantly noticed within the analyses of various subgroups of dose-response indicators and the decreased danger related to metformin use was constantly noticed in numerous sensitivity analyses.
A median day by day dose of 1000-1500 mg/day can considerably scale back the chance by > 50%. The profit didn’t differ between totally different formulations of metformin, and the estimated hazard ratio for standard/immediate-release metformin versus by no means customers was 0.516 (0.441-0.603) and was 0.509 (0.421-0.615) for extended/slow-release metformin versus by no means customers. It’s concluded that metformin use is related to a decreased danger of acute appendicitis in sufferers with sort 2 diabetes mellitus.
Affiliation of severity of diabetic retinopathy with corneal endothelial and thickness modifications in sufferers with diabetes mellitus
Goal: To analyse the central corneal thickness, endothelial cell density and morphology in sufferers with diabetes mellitus (DM).
Strategies: We analysed corneal endothelium, i.e. central corneal thickness (CCT), endothelial cell density (ECD), coefficient of variation in cell measurement (CV), and hexagonality (Hex) with specular microscopy in sufferers with sort 2 DM and in contrast with age-matched controls. The affect of diabetic retinopathy (DR) severity, period of DM, and degree of glycosylated haemoglobin (HbA1c) was additionally analysed.
Outcomes: The examine cohort included 592 eyes of 592 diabetic sufferers and 596 eyes of 596 management topics. A big distinction was present in CCT (522.1 ± 36.6 μm in DM, 514.9 ± 37.1 μm in controls; P = 0.001), ECD (2484.5 ± 299.5 cells/mm2 in DM, 2555.9 ± 258.2 cells/mm2 in controls; P = 0.017), CV (40.3 ± 6.1 in DM, 37.2 ± 6.1 in controls; P < 0.001) and Hex (39.9 ± 5.2 in DM, 44.6 ± 6.Zero in controls; P < 0.001). The longer period of DM ( > 10 years) and poor glycaemic management (HbA1c > 7.5%) had been related to related outcomes. A considerably decreased ECD (P < 0.001) and Hex (P = 0.001) and better CV (P = 0.007) and CCT (P = 0.01) was famous when assessed towards numerous phases of DR. Multivariate evaluation confirmed that growing age was considerably related to decrease ECD (P < 0.001), Hex (P < 0.001), and CCT (P = 0.004); and the next CV (P < 0.001).
Conclusions: DM has deleterious results on corneal endothelium and thickness. The presence of DR might additional warrant a radical corneal analysis, particularly when planning intraocular surgical procedure.
Affiliation of interior retinal reflectivity with qualitative and quantitative modifications in retinal layers over time in diabetic eyes with out retinopathy
Goal: To evaluate the course of neurodegeneration primarily based on retinal layer thickness and integrity evaluation in diabetic sufferers with out retinopathy and to judge its affiliation with interior retinal reflectivity.
Strategies: This retrospective case-control examine included 80 eyes of 80 sufferers with DM with out retinopathy and 40 eyes of 40 wholesome topics with a follow-up of ≥1 12 months. SD-OCT was used for evaluation of retinal reflectivity and macular layer thicknesses. Optical depth ratios (OIRs) had been outlined because the imply OCT reflectivity of ganglion cell and interior nuclear layer to the imply reflectivity of RPE.
Outcomes: After Bonferroni correction, thinning in pericentral, superior and nasal sectors in whole retina, superior ganglion cell, pericentral and nasal interior plexiform, and superior interior retinal layers, in addition to thickening in inferior and pericentral outer plexiform layer remained vital within the examine group (p < 0.0125). Ganglion cell layer OIR considerably correlated with the modifications in superior retina (r = 0.278, p = 0.013), central interior retina (r = 0.247, p = 0.027), and pericentral retinal thickness (r = 0.240, p = 0.032), and no eyes had disruption of retinal layers within the examine group initially or lastly.
Conclusion: Ganglion cell layer reflectivity considerably correlated with the quantity of pericentral retinal thinning through the time course within the diabetic group, which was extra outstanding within the interior retinal layers.
RRAD Antibody |
|||
1-CSB-PA003910 | Cusabio |
|
|
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/20000 |
RRAD Antibody |
|||
CSB-PA233809- | Cusabio | each | EUR 402 |
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500 |
RRAD Antibody |
|||
CSB-PA233809-100ul | Cusabio | 100ul | EUR 379.2 |
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500 |
RRAD Antibody |
|||
1-CSB-PA248209 | Cusabio |
|
|
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:25-1:100 |
RRAD Antibody |
|||
1-CSB-PA779820 | Cusabio |
|
|
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200 |
RRAD Antibody |
|||
R34275-100UG | NSJ Bioreagents | 100 ug | EUR 339.15 |
Description: Additional name(s) for this target protein: Ras-related associated with diabetes |
Polyclonal RRAD Antibody |
|||
APR05556G | Leading Biology | 0.1ml | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RRAD . This antibody is tested and proven to work in the following applications: |
RRAD Conjugated Antibody |
|||
C37229 | SAB | 100ul | EUR 476.4 |
GTP-binding protein RAD (RRAD) Antibody |
|||
20-abx241706 | Abbexa |
|
|
GTP-binding protein RAD (RRAD) Antibody |
|||
20-abx214509 | Abbexa |
|
|
GTP-binding protein RAD (RRAD) Antibody |
|||
20-abx324872 | Abbexa |
|
|
GTP-binding protein RAD (RRAD) Antibody |
|||
abx332370-100ul | Abbexa | 100 ul | EUR 510 |
GTP-Binding Protein RAD (RRAD) Antibody |
|||
abx432011-200ul | Abbexa | 200 ul | EUR 460.8 |
GTP-Binding Protein RAD (RRAD) Antibody |
|||
20-abx008742 | Abbexa |
|
|
Rrad/ Rat Rrad ELISA Kit |
|||
ELI-14921r | Lifescience Market | 96 Tests | EUR 1063.2 |
RRAD And GEM Like GTPase 2 (REM2) Antibody |
|||
abx237237-100ug | Abbexa | 100 ug | EUR 661.2 |
RRAD And GEM Like GTPase 2 (REM2) Antibody |
|||
abx122938-100ug | Abbexa | 100 ug | EUR 469.2 |
Polyclonal RRAD (aa36-48) Antibody (internal region) |
|||
APG00807G | Leading Biology | 0.1mg | EUR 580.8 |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human RRAD (aa36-48) (internal region). This antibody is tested and proven to work in the following applications: |
RRAD siRNA |
|||
20-abx932133 | Abbexa |
|
|
RRAD Peptide |
|||
43-008P | ProSci | 0.1 mg | EUR 405.6 |
Description: RRAD Peptide |
RRAD Blocking Peptide |
|||
20-abx063234 | Abbexa |
|
|
RRAD Blocking Peptide |
|||
33R-10070 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RRAD antibody, catalog no. 70R-5798 |
RRAD Blocking Peptide |
|||
33R-4793 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RRAD antibody, catalog no. 70R-5797 |
Anti-RRAD (aa36-48) antibody |
|||
STJ72757 | St John's Laboratory | 100 µg | EUR 430.8 |
RRAD ELISA KIT|Human |
|||
EF005507 | Lifescience Market | 96 Tests | EUR 826.8 |
Human RRAD shRNA Plasmid |
|||
20-abx954199 | Abbexa |
|
|
RRAD Recombinant Protein (Rat) |
|||
RP226925 | ABM | 100 ug | Ask for price |
RRAD Recombinant Protein (Mouse) |
|||
RP169340 | ABM | 100 ug | Ask for price |
RRAD Recombinant Protein (Human) |
|||
RP095493 | ABM | 100 ug | Ask for price |
Rrad ORF Vector (Rat) (pORF) |
|||
ORF075643 | ABM | 1.0 ug DNA | EUR 607.2 |
RRAD ORF Vector (Human) (pORF) |
|||
ORF031832 | ABM | 1.0 ug DNA | EUR 486 |
Rrad ORF Vector (Mouse) (pORF) |
|||
ORF056448 | ABM | 1.0 ug DNA | EUR 607.2 |
Rrad sgRNA CRISPR Lentivector set (Rat) |
|||
K7052701 | ABM | 3 x 1.0 ug | EUR 406.8 |
Rrad 3'UTR GFP Stable Cell Line |
|||
TU168183 | ABM | 1.0 ml | Ask for price |
RRAD 3'UTR GFP Stable Cell Line |
|||
TU072380 | ABM | 1.0 ml | EUR 1672.8 |
Rrad 3'UTR GFP Stable Cell Line |
|||
TU269725 | ABM | 1.0 ml | Ask for price |
Rrad sgRNA CRISPR Lentivector set (Mouse) |
|||
K3480701 | ABM | 3 x 1.0 ug | EUR 406.8 |
RRAD sgRNA CRISPR Lentivector set (Human) |
|||
K2069901 | ABM | 3 x 1.0 ug | EUR 406.8 |
RRAD Protein Vector (Rat) (pPM-C-HA) |
|||
PV302572 | ABM | 500 ng | EUR 723.6 |
RRAD Protein Vector (Rat) (pPB-C-His) |
|||
PV302570 | ABM | 500 ng | EUR 723.6 |
RRAD Protein Vector (Rat) (pPB-N-His) |
|||
PV302571 | ABM | 500 ng | EUR 723.6 |
RRAD Protein Vector (Rat) (pPM-C-His) |
|||
PV302573 | ABM | 500 ng | EUR 723.6 |
RRAD Protein Vector (Human) (pPM-C-HA) |
|||
PV127328 | ABM | 500 ng | EUR 662.4 |
RRAD Protein Vector (Mouse) (pPM-C-HA) |
|||
PV225792 | ABM | 500 ng | EUR 723.6 |
RRAD Protein Vector (Human) (pPB-C-His) |
|||
PV127326 | ABM | 500 ng | EUR 662.4 |
RRAD Protein Vector (Human) (pPB-N-His) |
|||
PV127327 | ABM | 500 ng | EUR 662.4 |
RRAD Protein Vector (Human) (pPM-C-His) |
|||
PV127329 | ABM | 500 ng | EUR 662.4 |
RRAD Protein Vector (Mouse) (pPB-C-His) |
|||
PV225790 | ABM | 500 ng | EUR 723.6 |
RRAD Protein Vector (Mouse) (pPB-N-His) |
|||
PV225791 | ABM | 500 ng | EUR 723.6 |
RRAD Protein Vector (Mouse) (pPM-C-His) |
|||
PV225793 | ABM | 500 ng | EUR 723.6 |
Rrad 3'UTR Luciferase Stable Cell Line |
|||
TU118183 | ABM | 1.0 ml | Ask for price |
RRAD 3'UTR Luciferase Stable Cell Line |
|||
TU022380 | ABM | 1.0 ml | EUR 1672.8 |
Rrad 3'UTR Luciferase Stable Cell Line |
|||
TU219725 | ABM | 1.0 ml | Ask for price |
Rrad sgRNA CRISPR Lentivector (Rat) (Target 1) |
|||
K7052702 | ABM | 1.0 ug DNA | EUR 184.8 |
Rrad sgRNA CRISPR Lentivector (Rat) (Target 2) |
|||
K7052703 | ABM | 1.0 ug DNA | EUR 184.8 |
Rrad sgRNA CRISPR Lentivector (Rat) (Target 3) |
|||
K7052704 | ABM | 1.0 ug DNA | EUR 184.8 |
Rrad sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
K3480702 | ABM | 1.0 ug DNA | EUR 184.8 |
Rrad sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
K3480703 | ABM | 1.0 ug DNA | EUR 184.8 |
Rrad sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
K3480704 | ABM | 1.0 ug DNA | EUR 184.8 |
RRAD sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
K2069902 | ABM | 1.0 ug DNA | EUR 184.8 |
RRAD sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
K2069903 | ABM | 1.0 ug DNA | EUR 184.8 |
RRAD sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
K2069904 | ABM | 1.0 ug DNA | EUR 184.8 |
Rat GTP-binding protein RAD (RRAD) ELISA Kit |
|||
abx391893-96tests | Abbexa | 96 tests | EUR 1093.2 |
Human GTP- binding protein RAD, RRAD ELISA KIT |
|||
ELI-35549h | Lifescience Market | 96 Tests | EUR 988.8 |
Mouse GTP- binding protein RAD, Rrad ELISA KIT |
|||
ELI-14089m | Lifescience Market | 96 Tests | EUR 1038 |
Mouse GTP-binding protein RAD (RRAD) ELISA Kit |
|||
abx390415-96tests | Abbexa | 96 tests | EUR 1093.2 |
Human GTP-binding protein RAD (RRAD) ELISA Kit |
|||
abx385354-96tests | Abbexa | 96 tests | EUR 1093.2 |
RRAD Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV) |
|||
LV658369 | ABM | 1.0 ug DNA | EUR 616.8 |
RRAD Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
LV658373 | ABM | 1.0 ug DNA | EUR 616.8 |
RRAD Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
LV658374 | ABM | 1.0 ug DNA | EUR 616.8 |
Human RRAD And GEM Like GTPase 2 (REM2) ELISA Kit |
|||
abx382769-96tests | Abbexa | 96 tests | EUR 1093.2 |
Rrad ELISA Kit| Rat GTP-binding protein RAD ELISA Kit |
|||
EF019253 | Lifescience Market | 96 Tests | EUR 826.8 |
Rrad ELISA Kit| Mouse GTP-binding protein RAD ELISA Kit |
|||
EF016057 | Lifescience Market | 96 Tests | EUR 826.8 |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
|||
K7052705 | ABM | 3 x 1.0 ug | EUR 451.2 |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|||
K3480705 | ABM | 3 x 1.0 ug | EUR 451.2 |
RRAD sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
K2069905 | ABM | 3 x 1.0 ug | EUR 451.2 |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1) |
|||
K7052706 | ABM | 1.0 ug DNA | EUR 200.4 |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2) |
|||
K7052707 | ABM | 1.0 ug DNA | EUR 200.4 |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3) |
|||
K7052708 | ABM | 1.0 ug DNA | EUR 200.4 |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
|||
K3480706 | ABM | 1.0 ug DNA | EUR 200.4 |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
|||
K3480707 | ABM | 1.0 ug DNA | EUR 200.4 |
Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
|||
K3480708 | ABM | 1.0 ug DNA | EUR 200.4 |
RRAD sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
K2069906 | ABM | 1.0 ug DNA | EUR 200.4 |
RRAD sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
K2069907 | ABM | 1.0 ug DNA | EUR 200.4 |
RRAD sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
K2069908 | ABM | 1.0 ug DNA | EUR 200.4 |
RRAD Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA) |
|||
LV658370 | ABM | 1.0 ug DNA | EUR 616.8 |
RRAD Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
|||
LV658371 | ABM | 1.0 ug DNA | EUR 686.4 |
RRAD Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
|||
LV658372 | ABM | 1.0 ug DNA | EUR 686.4 |
anti- RRAS antibody |
|||
FNab07489 | FN Test | 100µg | EUR 658.5 |
Description: Antibody raised against RRAS |
anti- RRAGB antibody |
|||
FNab07488 | FN Test | 100µg | EUR 658.5 |
Description: Antibody raised against RRAGB |
anti- RRAS2 antibody |
|||
FNab07490 | FN Test | 100µg | EUR 658.5 |
Description: Antibody raised against RRAS2 |
Rat Anti-Mouse IFNγ Monoclonal antibody, clone R4-6A2 |
|||
CABT-L4328-1mg | Creative Diagnostics | 1 mg | EUR 1076.4 |
Rat Anti-Mouse IFNγ Monoclonal antibody, clone R4-6A2 |
|||
CABT-L4328-5mg | Creative Diagnostics | 5 mg | EUR 2886 |
RRAGA / RRAGB Antibody |
|||
abx332724-100ul | Abbexa | 100 ul | EUR 510 |
RRAGA / RRAGB Antibody |
|||
20-abx328592 | Abbexa |
|
|
RRAGA/RRAGB Antibody |
|||
1-CSB-PA003930 | Cusabio |
|
|
Description: A polyclonal antibody against RRAGA/RRAGB. Recognizes RRAGA/RRAGB from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/20000 |
RRAGA/RRAGB Antibody |
|||
CSB-PA590465- | Cusabio | each | EUR 402 |
Description: A polyclonal antibody against RRAGA/RRAGB. Recognizes RRAGA/RRAGB from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000 |
RRAGA/RRAGB Antibody |
|||
CSB-PA590465-100ul | Cusabio | 100ul | EUR 379.2 |
Description: A polyclonal antibody against RRAGA/RRAGB. Recognizes RRAGA/RRAGB from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000 |
Anti-Anti-SEPT5 Antibody antibody |
|||
STJ114819 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
Anti-Anti-SEPT2 Antibody antibody |
|||
STJ28365 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT7 Antibody antibody |
|||
STJ28963 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
Anti-Anti-SEPT3 Antibody antibody |
|||
STJ118990 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT1 antibody antibody |
|||
STJ119580 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis and the maintenance of cellular morphology. This gene encodes a protein that can form homo- and heterooligomeric filaments, and may contribute to the formation of neurofibrillary tangles in Alzheimer's disease. Alternatively spliced transcript variants have been found but the full-length nature of these variants has not been determined. [provided by RefSeq, Dec 2012] |
Anti-Anti-SEPT6 antibody antibody |
|||
STJ11100949 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis. One version of pediatric acute myeloid leukemia is the result of a reciprocal translocation between chromosomes 11 and X, with the breakpoint associated with the genes encoding the mixed-lineage leukemia and septin 2 proteins. This gene encodes four transcript variants encoding three distinct isoforms. An additional transcript variant has been identified, but its biological validity has not been determined. |
Anti-Anti-SEPT9 Antibody antibody |
|||
STJ111369 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described. |
Anti-Anti-SEPT4 Antibody antibody |
|||
STJ112276 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is highly expressed in brain and heart. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. One of the isoforms (known as ARTS) is distinct; it is localized to the mitochondria, and has a role in apoptosis and cancer. |
Anti-Anti-SEPT7 Antibody antibody |
|||
STJ116214 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
Anti-Anti-SEPT8 Antibody antibody |
|||
STJ117206 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
Anti-Anti-SEPT2 Antibody antibody |
|||
STJ25475 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT5 Antibody antibody |
|||
STJ25477 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
Anti-Anti-SEPT8 Antibody antibody |
|||
STJ25479 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
Anti-Anti-MARCH9 Antibody antibody |
|||
STJ112609 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT11 Antibody antibody |
|||
STJ113941 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT11 Antibody antibody |
|||
STJ114081 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-MARCH8 Antibody antibody |
|||
STJ114828 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT12 Antibody antibody |
|||
STJ117759 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene encodes a guanine-nucleotide binding protein and member of the septin family of cytoskeletal GTPases. Septins play important roles in cytokinesis, exocytosis, embryonic development, and membrane dynamics. Multiple transcript variants encoding different isoforms have been found for this gene. |
Anti-Anti-MARCH6 Antibody antibody |
|||
STJ118549 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-MARCH6 Antibody antibody |
|||
STJ118550 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-MARCH7 Antibody antibody |
|||
STJ118752 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT11 Antibody antibody |
|||
STJ111530 | St John's Laboratory | 100 µl | EUR 332.4 |
Rat Anti-Mouse IL-12 p75 Monoclonal antibody, clone R2-9A5 |
|||
CABT-L4486-1mg | Creative Diagnostics | 1 mg | EUR 1076.4 |
Rat Anti-Mouse IL-12 p75 Monoclonal antibody, clone R2-9A5 |
|||
CABT-L4486-5mg | Creative Diagnostics | 5 mg | EUR 2886 |
RRAS Antibody |
|||
37881-100ul | SAB | 100ul | EUR 302.4 |
RRAS antibody |
|||
70R-20022 | Fitzgerald | 50 ul | EUR 522 |
Description: Rabbit polyclonal RRAS antibody |
RRAS Antibody |
|||
1-CSB-PA020513GA01HU | Cusabio |
|
|
Description: A polyclonal antibody against RRAS. Recognizes RRAS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC |
RRAS Antibody |
|||
1-CSB-PA444135 | Cusabio |
|
|
Description: A polyclonal antibody against RRAS. Recognizes RRAS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100 |
RRAS Antibody |
|||
1-CSB-PA663638 | Cusabio |
|
|
Description: A polyclonal antibody against RRAS. Recognizes RRAS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100 |
RRAGC antibody |
|||
10R-1679 | Fitzgerald | 100 ug | EUR 614.4 |
Description: Mouse monoclonal RRAGC antibody |
RRAGA Antibody |
|||
40326-100ul | SAB | 100ul | EUR 302.4 |
RRAGC Antibody |
|||
40327-100ul | SAB | 100ul | EUR 302.4 |
RRAS2 Antibody |
|||
40328-100ul | SAB | 100ul | EUR 302.4 |
RRAS2 Antibody |
|||
7249-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: RRAS2 Antibody: Activating mutations and overexpression of classical Ras subfamily members (K-RAS, N-RAS and H-RAS) have been widely investigated as key events in the development of human cancers. The RRAS subfamily of Ras-related proteins includes RRAS1, RRAS2 (TC21) and RRAS3 (M-Ras) show overall amino acid identity with the classical Ras subfamily (H-Ras, K-Ras and N-Ras) of 55–60%. RRAS2 is a small GTPbinding protein of the Ras superfamily of GTPases. It might transduce growth inhibitory signals across the cell membrane, exerting its effect through an effector shared with the Ras proteins. RRAS2 has high oncogenic potential and overexpression/mutations have been reported in several tumor tissues and cell lines. |